Structure Therapeutics (GPCR) Other financing activities (2022 - 2026)

Structure Therapeutics' Other financing activities history runs 5 years deep, the most recent figure standing at $37000.0 for Q1 2026.

• In Q1 2026, Other financing activities fell 76.28% year-over-year to $37000.0; the TTM figure through Mar 2026 stood at $1.9 million (changed 0.32% YoY), while the FY2025 annual figure was $2.0 million, up 12.47% from the prior year.
• Other financing activities was $37000.0 for Q1 2026 at Structure Therapeutics, down from $1.2 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $18.5 million in Q4 2023 to a low of $37000.0 in Q1 2026.
• Historically, Other financing activities has averaged $2.0 million across 5 years, with a median of $469000.0 in 2023.
• The sharpest annual moves came in 2023 and 2024: Other financing activities jumped 5750.63% in 2023, then tumbled 97.96% in 2024.
• A 5-year view of Other financing activities shows it stood at $316000.0 in 2022, then surged by 5750.63% to $18.5 million in 2023, then tumbled by 93.76% to $1.2 million in 2024, then advanced by 8.32% to $1.2 million in 2025, then plunged by 97.04% to $37000.0 in 2026.
• The last three Other financing activities figures came in at $37000.0 (Q1 2026), $1.2 million (Q4 2025), and $462000.0 (Q3 2025), per Business Quant data.